113 related articles for article (PubMed ID: 17406232)
1. In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature.
Roesli C; Neri D; Rybak JN
Nat Protoc; 2006; 1(1):192-9. PubMed ID: 17406232
[TBL] [Abstract][Full Text] [Related]
2. In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature.
Rybak JN; Ettorre A; Kaissling B; Giavazzi R; Neri D; Elia G
Nat Methods; 2005 Apr; 2(4):291-8. PubMed ID: 15782212
[TBL] [Abstract][Full Text] [Related]
3. A novel reactive ester derivative of biotin with reduced membrane permeability for in vivo biotinylation experiments.
Strassberger V; Trüssel S; Fugmann T; Neri D; Roesli C
Proteomics; 2010 Oct; 10(19):3544-8. PubMed ID: 20821733
[TBL] [Abstract][Full Text] [Related]
4. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
Kischel P; Waltregny D; Castronovo V
Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
[TBL] [Abstract][Full Text] [Related]
5. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.
Castronovo V; Kischel P; Guillonneau F; de Leval L; Deféchereux T; De Pauw E; Neri D; Waltregny D
Proteomics; 2007 Apr; 7(8):1188-96. PubMed ID: 17372937
[TBL] [Abstract][Full Text] [Related]
6. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
[TBL] [Abstract][Full Text] [Related]
7. The pivotal role of reactivity in the design of novel biotinylation reagents for the chemical-proteomics-based identification of vascular accessible biomarkers.
Hanke SA; Kerner A; Nadler WM; Trumpp A; Zhang Y; Rösli CP
J Proteomics; 2016 Jun; 141():57-66. PubMed ID: 27113135
[TBL] [Abstract][Full Text] [Related]
8. Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis.
Conrotto P; Roesli C; Rybak J; Kischel P; Waltregny D; Neri D; Castronovo V
Int J Cancer; 2008 Dec; 123(12):2856-64. PubMed ID: 18798264
[TBL] [Abstract][Full Text] [Related]
9. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.
Rybak JN; Roesli C; Kaspar M; Villa A; Neri D
Cancer Res; 2007 Nov; 67(22):10948-57. PubMed ID: 18006840
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylated proteins: purification and identification.
Wan J; Roth AF; Bailey AO; Davis NG
Nat Protoc; 2007; 2(7):1573-84. PubMed ID: 17585299
[TBL] [Abstract][Full Text] [Related]
11. A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer.
Castronovo V; Waltregny D; Kischel P; Roesli C; Elia G; Rybak JN; Neri D
Mol Cell Proteomics; 2006 Nov; 5(11):2083-91. PubMed ID: 16861259
[TBL] [Abstract][Full Text] [Related]
12. Improved protein sequence coverage by on resin deglycosylation and cysteine modification for biomarker discovery.
Kamada H; Fugmann T; Neri D; Roesli C
Proteomics; 2009 Feb; 9(3):783-7. PubMed ID: 19137555
[TBL] [Abstract][Full Text] [Related]
13. Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusion.
Wu J; Liu W; Sousa E; Qiu Y; Pittman DD; Maganti V; Feldman J; Gill D; Lu Z; Dorner AJ; Schaub R; Tan XY
J Proteome Res; 2007 Dec; 6(12):4728-36. PubMed ID: 17997517
[TBL] [Abstract][Full Text] [Related]
14. Detection of protein S-nitrosation using irreversible biotinylation procedures (IBP).
Huang B; Chen C
Free Radic Biol Med; 2010 Aug; 49(3):447-56. PubMed ID: 20466056
[TBL] [Abstract][Full Text] [Related]
15. Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer.
Strassberger V; Fugmann T; Neri D; Roesli C
J Proteomics; 2010 Sep; 73(10):1954-73. PubMed ID: 20538087
[TBL] [Abstract][Full Text] [Related]
16. Generally detected proteins in comparative proteomics--a matter of cellular stress response?
Wang P; Bouwman FG; Mariman EC
Proteomics; 2009 Jun; 9(11):2955-66. PubMed ID: 19415655
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells.
Roesli C; Borgia B; Schliemann C; Gunthert M; Wunderli-Allenspach H; Giavazzi R; Neri D
Cancer Res; 2009 Jul; 69(13):5406-14. PubMed ID: 19491280
[TBL] [Abstract][Full Text] [Related]
18. Plasma-derived microparticles for biomarker discovery.
Smalley DM; Ley K
Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
[TBL] [Abstract][Full Text] [Related]
19. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of cartilage proteins.
Wilson R; Belluoccio D; Bateman JF
Methods; 2008 May; 45(1):22-31. PubMed ID: 18442702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
